Galmed Pharmaceuticals (EOCN) Price to Earnings (2014 - 2024)
Galmed Pharmaceuticals' (EOCN) Price to Earnings stood at 0.42 in Q3 2024, up 56.0% from 0.27 a year earlier and up 83.6% from the prior quarter.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Price to Earnings (2014 - 2024) Analysis & Trends
For FY2023, Galmed Pharmaceuticals' Price to Earnings came in at 0.18, down 74.2% from FY2022.
- Annual Price to Earnings has declined for five straight years.
- Across earlier years, Price to Earnings came in at 0.71 in FY2022 (-49.8%), 1.41 in FY2021 (-39.0%), 2.31 in FY2020 (-61.4%) and 5.97 in FY2019 (-59.0%).
- The Q3 2024 figure is the highest quarterly Price to Earnings since Q2 2023.
- On a year-over-year basis, Price to Earnings rose in 1 of the last eight quarters, with an average decline of 45.2%.
- Peak year-over-year performance for Price to Earnings in the last five years was growth of 56.0% in Q3 2024, against a decline of 82.8% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.23 (Q2 2024), 0.25 (Q1 2024) and 0.39 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Galmed Pharmaceuticals | 420,034.32 | 420,034.32 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 0.42 |
| Jun 30, 2024 | 0.23 |
| Mar 31, 2024 | 0.25 |
| Dec 31, 2023 | 0.39 |
| Sep 30, 2023 | 0.27 |
| Jun 30, 2023 | 0.65 |
| Mar 31, 2023 | 1.09 |
| Dec 31, 2022 | 2.26 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 1.28 |
| Mar 31, 2022 | 2.29 |
| Dec 31, 2021 | 3.12 |
| Sep 30, 2021 | 3.40 |
| Jun 30, 2021 | 3.89 |
| Mar 31, 2021 | 5.30 |
| Dec 31, 2020 | 3.98 |
| Sep 30, 2020 | 5.09 |
| Jun 30, 2020 | 8.24 |
| Mar 31, 2020 | 6.71 |
| Dec 31, 2019 | 5.97 |
API Access
Galmed Pharmaceuticals Price to Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-earnings&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-earnings", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-earnings&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();